Bioprox Healthcare leverages its industrial team’s expertise, advanced fermentation equipment and 45 years of experience to assess the feasibility of your project and optimize the production of your proprietary strains.
Bioprox operates a dedicated, high-capacity facility for biomass production including:
- Fermentation
- Concentration
- freeze-drying
- Formulation
—
Development studies to optimize cultivation conditions of novel strains.
—
Stability enhancement of freeze-dried powder
—
Fermenters up to 30 L
—
Intermediate step in industrial scale-up
—
Possibility to obtain an inicial quantity of freeze dried powder for validations and clinical trials
—
Fermenters up to 1 000 L
—
Freeze-dried powder produced at an industrial scale with reproducible quality, formulated as single strains or blends, protected by triple foil bags.
—
Fermenters up to 10 000 L
—
Integration of state-of-the-art technologies to maximize productivity.
Bioprox Healthcare ensures rigorous control over all dowstream processes at our facility, enabling the industrial-scale production of your propietary biological materials with precision and reliability.
In case of tech transfer, Bioprox Healthcare ensures precise adherence to your manufacturing processes, while safeguarding and respecting your proprietary know-how.
Our CMO and CDMO services ensure best in class production performance while meeting your quality requirements (specifications, stability, etc.) for probiotics in nutraceuticals, food, petfood and cosmetics.
Interested?
S.svg){kind=logo}